AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.
Artificial intelligence is beginning to play a larger role in one of healthcare’s most difficult areas: finding treatments for brain disorders. Researchers and biotech companies are now exploring how AI can help accelerate drug discovery for conditions such as Alzheimer’s disease, Parkinson’s, dementia, and motor neurone disease (MND).
Developing drugs for neurological disorders has traditionally been a slow and expensive process. Scientists often spend years studying patient data, testing chemical compounds, and conducting multiple rounds of research before identifying a potential treatment candidate. Many drugs fail during testing stages, making the process both high-risk and resource-intensive.
